grekovВестник хирургии имени И.И. ГрековаGrekov's Bulletin of Surgery0042-4625Federal State Budgetary Educational Institution of Higher Education «Academician I.P. Pavlov First St. Petersburg State Medical University» of the Ministry of Healthcare of the Russion Federation, FSBEI HE I.P.Pavlov SPbSMU MOH Russiagrekov-104Research ArticleОБЗОРЫREVIEWSТКАНЕВАЯ ИНЖЕНЕРИЯ В ХИРУРГИИ СОСУДОВАлександровВ. Н.vnaleks9@yandex.ruКривенцовА. В.sascha_jiembet@mail.ruХубулаваГ. Г.khubulava@clubcvs.ruКалюжная-ЗемлянаяЛ. И.terrestra@mail.ruФирсановД. В.dfirsanov@gmail.comКондратенкоА. А.Akondratenko@mail.ruСанкт-Петербургский государственный педиатрический медицинский университетRussian Federation2015280820151744108112Copyright © Александров В.Н., Кривенцов А.В., Хубулава Г.Г., Калюжная-Земляная Л.И., Фирсанов Д.В., Кондратенко А.А., 20152015Александров В.Н., Кривенцов А.В., Хубулава Г.Г., Калюжная-Земляная Л.И., Фирсанов Д.В., Кондратенко А.А.Александров В.Н., Кривенцов А.В., Хубулава Г.Г., Калюжная-Земляная Л.И., Фирсанов Д.В., Кондратенко А.А.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.vestnik-grekova.ru/jour/article/view/104сосудистый протезтромбозтканевая инженериядецеллюляризациясосудистый каркасбиосовместимостьэндотелиймононуклеарная фракциятрансплантацияReferencesАхмедов Ш. Д., Афанасьев С. А., Егорова М. В. и др. Использование бесклеточного коллагенового матрикса в качестве платформы для изготовления кровеносных сосудов в сердечно-сосудистой хирургии // Ангиол. и сосуд. хир. 2012. № 2. С. 7-12.Ахмедов Ш. Д., Афанасьев С. А., Егорова М. В. и др. Использование бесклеточного коллагенового матрикса в качестве платформы для изготовления кровеносных сосудов в сердечно-сосудистой хирургии // Ангиол. и сосуд. хир. 2012. № 2. С. 7-12.Баринов Э. Ф., Сулаева О. Н. Гастроинтестинальные фибробласты - роль в регуляции физиологической активности и репарации желудочно-кишечного тракта // Росс. журн. гастроэнтер., гепатол., колопроктол. 2010. № 3. С. 9-18.Баринов Э. Ф., Сулаева О. Н. Гастроинтестинальные фибробласты - роль в регуляции физиологической активности и репарации желудочно-кишечного тракта // Росс. журн. гастроэнтер., гепатол., колопроктол. 2010. № 3. С. 9-18.Assmann A., Akhyari P., Delfs C. et al. Development of a growing rat model for the in vivo assessment of engineered aortic conduit // J. Surg. Res. 2012. Vol. 176, № 2. P. 367-375.Assmann A., Akhyari P., Delfs C. et al. Development of a growing rat model for the in vivo assessment of engineered aortic conduit // J. Surg. Res. 2012. Vol. 176, № 2. P. 367-375.Bechtel J. F., Gellissen J., Erasmi A. W. et al. Mid-term findings on echocardiography and computed tomography after RVOT-reconstruction: comparison of decellularized (SynerGraft) and conventional allografts // Eur. J. Cardiothorac. Surg. 2005. Vol. 27. P. 410-415.Bechtel J. F., Gellissen J., Erasmi A. W. et al. Mid-term findings on echocardiography and computed tomography after RVOT-reconstruction: comparison of decellularized (SynerGraft) and conventional allografts // Eur. J. Cardiothorac. Surg. 2005. Vol. 27. P. 410-415.Brown M. A., Zhang L. S., Levering V.W. et al. Human umbilical cord blood-derived endothelial cells reendothelialize vein grafts and prevent thrombosis // Arterioscler. Thromb. Vasc. Biol. 2010. Vol. 30. P. 2150-2155.Brown M. A., Zhang L. S., Levering V.W. et al. Human umbilical cord blood-derived endothelial cells reendothelialize vein grafts and prevent thrombosis // Arterioscler. Thromb. Vasc. Biol. 2010. Vol. 30. P. 2150-2155.Cebotari S., Lichtenberg A., Tudorache I. et al. Clinical application of tissue engineered human heart valves using autologous progenitor cells // Circulation. 2006. Vol. 114 (Suppl. 1). P. I132- I137.Cebotari S., Lichtenberg A., Tudorache I. et al. Clinical application of tissue engineered human heart valves using autologous progenitor cells // Circulation. 2006. Vol. 114 (Suppl. 1). P. I132- I137.Cho S. W., Kim I. K., Kang J. M. et al. Evidence for in vivo growth potential and vascular remodeling of tissue-engineered artery // Tissue Eng. Part A. 2009. Vol. 15, № 4. P. 901-912.Cho S. W., Kim I. K., Kang J. M. et al. Evidence for in vivo growth potential and vascular remodeling of tissue-engineered artery // Tissue Eng. Part A. 2009. Vol. 15, № 4. P. 901-912.Cho S. W., Lim J. E., Chu H. S. et al. Enhancement of in vivo endothelialization of tissue engineered vascular grafts by granulocyte colonystimulating factor // J. Biomed. Mater. Res. 2006. Vol. 76A. P. 252-263.Cho S. W., Lim J. E., Chu H. S. et al. Enhancement of in vivo endothelialization of tissue engineered vascular grafts by granulocyte colonystimulating factor // J. Biomed. Mater. Res. 2006. Vol. 76A. P. 252-263.Dohmen P. M., Lembcke A., Hotz H. et al. Ross operation with a tissue-engineered heart valve // Ann. Thorac. Surg. 2002. Vol. 74. P. 1438-1442.Dohmen P. M., Lembcke A., Hotz H. et al. Ross operation with a tissue-engineered heart valve // Ann. Thorac. Surg. 2002. Vol. 74. P. 1438-1442.Funamoto S., Nam K., Kimura T. et al. The use of highhydrostatic pressure treatment to decellularize blood vessels // Biomaterials. 2010. Vol. 31. P. 3590-3595.Funamoto S., Nam K., Kimura T. et al. The use of highhydrostatic pressure treatment to decellularize blood vessels // Biomaterials. 2010. Vol. 31. P. 3590-3595.Gui L., Muto A., Chan S. A. et al. Development of decellularized human umbilical arteries as small-diameter vascular grafts // Tissue Engineering. Part A. 2009. Vol. 15, № 9. P. 2665-2676.Gui L., Muto A., Chan S. A. et al. Development of decellularized human umbilical arteries as small-diameter vascular grafts // Tissue Engineering. Part A. 2009. Vol. 15, № 9. P. 2665-2676.Hashi C. K., Zhu Y.Q., Yang G. Y. et al. Antithrombogenic property of bone marrow mesenchymal stem cells in nanofibrous vascular grafts // Proc. Natl. Acad. Sci. USA. 2007. Vol. 104. P. 11915- 11920.Hashi C. K., Zhu Y.Q., Yang G. Y. et al. Antithrombogenic property of bone marrow mesenchymal stem cells in nanofibrous vascular grafts // Proc. Natl. Acad. Sci. USA. 2007. Vol. 104. P. 11915- 11920.Hibino N., Yi T., Duncan D. R. et al. A critical role for macrophages in neovessel formation and the development of stenosis in tissue-engineered vascular grafts // FASEB J. 2011. Vol. 12. P. 4253- 4263.Hibino N., Yi T., Duncan D. R. et al. A critical role for macrophages in neovessel formation and the development of stenosis in tissue-engineered vascular grafts // FASEB J. 2011. Vol. 12. P. 4253- 4263.Hjortnaes J., Gottlieb D., Figueiredo J. L. et al. Intravital molecular imaging of small-diameter tissue-engineered vascular grafts in mice: a feasibility study // Tissue Engl. Part. C: Methods. 2010. Vol. 16. P. 597-607.Hjortnaes J., Gottlieb D., Figueiredo J. L. et al. Intravital molecular imaging of small-diameter tissue-engineered vascular grafts in mice: a feasibility study // Tissue Engl. Part. C: Methods. 2010. Vol. 16. P. 597-607.Hwang S. J., Kim S. W., Choo S. J. et al. The decellularized vascular allograft as an experimental platform for developing a biocompatible small-diameter graft conduit in a rat surgical model // Yonsei Med. J. 2011. 52. P. 227-233.Hwang S. J., Kim S. W., Choo S. J. et al. The decellularized vascular allograft as an experimental platform for developing a biocompatible small-diameter graft conduit in a rat surgical model // Yonsei Med. J. 2011. 52. P. 227-233.Kallenbach K., Sorrentino S., Mertsching H. et al. A novel small-animal model for accelerated investigation of tissue-engineered aortic valve conduit // Tissue Engineering. Part C. 2010. Vol. 16, № 1. P. 41-50.Kallenbach K., Sorrentino S., Mertsching H. et al. A novel small-animal model for accelerated investigation of tissue-engineered aortic valve conduit // Tissue Engineering. Part C. 2010. Vol. 16, № 1. P. 41-50.Kaushal S., Amiel G. E., Guleserian K. J. et al. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo // Nat. Med. 2001. Vol. 7. P. 1035-1040.Kaushal S., Amiel G. E., Guleserian K. J. et al. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo // Nat. Med. 2001. Vol. 7. P. 1035-1040.Krawiec J. T., Vorp D. A. Adult stem cell-based tissue engineered blood vessels: A review // Biomaterials. 2012. 33. Р. 3388-3400.Krawiec J. T., Vorp D. A. Adult stem cell-based tissue engineered blood vessels: A review // Biomaterials. 2012. 33. Р. 3388-3400.Kim S. S., Lim S. H., Hong Y. S. et al. Tissue engineering of heart valves in vivo using bone marrow-derived cells // Artificial Organs. 2006. Vol. 30. P. 554-557.Kim S. S., Lim S. H., Hong Y. S. et al. Tissue engineering of heart valves in vivo using bone marrow-derived cells // Artificial Organs. 2006. Vol. 30. P. 554-557.Lichtenberg A., Tudorache I., Cebotari S. et al. In vitro re-endothelialization of detergent decellularized heart valves under simulated physiological dynamic conditions // Biomaterials. 2006. Vol. 27. P. 4221-4229.Lichtenberg A., Tudorache I., Cebotari S. et al. In vitro re-endothelialization of detergent decellularized heart valves under simulated physiological dynamic conditions // Biomaterials. 2006. Vol. 27. P. 4221-4229.Lichtenberg A., Tudorache I., Cebotari S. et al. Preclinical testing of tissue-engineered heart valvesre-endothelialized under simulated physiological conditions // Circulation. 2006. Vol. 114 (1 Suppl.). Р. I559-I565.Lichtenberg A., Tudorache I., Cebotari S. et al. Preclinical testing of tissue-engineered heart valvesre-endothelialized under simulated physiological conditions // Circulation. 2006. Vol. 114 (1 Suppl.). Р. I559-I565.Liu G. F., He Z. J., Yang D. P. et al. Decellularized aorta of fetal pigs as a potential scaffold for small diameter tissue engineered vascular graft // Chin. Med J. 2008. Vol. 121. P. 1398-1406.Liu G. F., He Z. J., Yang D. P. et al. Decellularized aorta of fetal pigs as a potential scaffold for small diameter tissue engineered vascular graft // Chin. Med J. 2008. Vol. 121. P. 1398-1406.Mirensky T. L., Hibino N., Sawh-Martinez R. F. et al. Tissue-engineered vascular grafts: does cell seeding matter? // J. Pediatr. Surg. 2010. Vol. 45. P. 1299-1305.Mirensky T. L., Hibino N., Sawh-Martinez R. F. et al. Tissue-engineered vascular grafts: does cell seeding matter? // J. Pediatr. Surg. 2010. Vol. 45. P. 1299-1305.Muller F., Gailani D., Renne T. Factor XI and XII as antithrombotic targets // Curr. Opin. Hematol. 2011. Vol. 18, № 5. Р. 349-355.Muller F., Gailani D., Renne T. Factor XI and XII as antithrombotic targets // Curr. Opin. Hematol. 2011. Vol. 18, № 5. Р. 349-355.Neff L. P., Tillman B. W., Yazdani S. K. et al. Vascular smooth muscle enhances functionality of tissue-engineered blood vessels in vivo // J. Vasc. Surg. 2011. Vol. 53. P. 426-434.Neff L. P., Tillman B. W., Yazdani S. K. et al. Vascular smooth muscle enhances functionality of tissue-engineered blood vessels in vivo // J. Vasc. Surg. 2011. Vol. 53. P. 426-434.Negishi J., Funamoto S., Kimura T. et al. Effect of treatment temperature on collagen structures of the decellularized carotid artery using highhydrostatic pressure // J. Artif. Organs. 2011. Vol. 14, № 3. Р. 223-231.Negishi J., Funamoto S., Kimura T. et al. Effect of treatment temperature on collagen structures of the decellularized carotid artery using highhydrostatic pressure // J. Artif. Organs. 2011. Vol. 14, № 3. Р. 223-231.Quint C., Arief M., Muto A. et al. Allogeneic human tissue-engineered blood vessel // J. Vasc. Surg. 2012. Vol. 55. P. 790- 798.Quint C., Arief M., Muto A. et al. Allogeneic human tissue-engineered blood vessel // J. Vasc. Surg. 2012. Vol. 55. P. 790- 798.Rieder E., Kasimir M.-T., Silberhumer G. et al. Decellularization protocols of porcine heart valves differ importantly in efficiency of cell removal and susceptibility of the matrix to recellularization with human vascular cells // J. Thorac. Cardiovasc. Surg. 2004. Vol. 127, № 2. P. 399-405.Rieder E., Kasimir M.-T., Silberhumer G. et al. Decellularization protocols of porcine heart valves differ importantly in efficiency of cell removal and susceptibility of the matrix to recellularization with human vascular cells // J. Thorac. Cardiovasc. Surg. 2004. Vol. 127, № 2. P. 399-405.Roh J. D., Sawh-Martinez R., Brennan M. P. et al. Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling // Proc. Natl. Acad. Sci. USA. 2010. Vol. 107. P. 4669-4674.Roh J. D., Sawh-Martinez R., Brennan M. P. et al. Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling // Proc. Natl. Acad. Sci. USA. 2010. Vol. 107. P. 4669-4674.Swartz D.D., Andreadis S. T. Animal models for vascular tissue engineering // Curr. Opin. Biotechnol. 2013. Vol. 24, Issue 5. P. 916-925.Swartz D.D., Andreadis S. T. Animal models for vascular tissue engineering // Curr. Opin. Biotechnol. 2013. Vol. 24, Issue 5. P. 916-925.Zehr K. J., Yagubyan M., Connolly H. M. et al. Aortic root replacement with a novel decellularized cryopreserved aortic homograft: postoperative immunoreactivity and early results // J. Thorac. Cardiovasc. Surg. 2005. Vol. 130. P. 1010-1015.Zehr K. J., Yagubyan M., Connolly H. M. et al. Aortic root replacement with a novel decellularized cryopreserved aortic homograft: postoperative immunoreactivity and early results // J. Thorac. Cardiovasc. Surg. 2005. Vol. 130. P. 1010-1015.Zeng W., Yuan W., Li L. et al. The promotion of endothelial progenitor cells recruitment by nerve growth factors in tissue engineered blood vessels // Biomaterials 2010. Vol. 31. P. 1636- 1645.Zeng W., Yuan W., Li L. et al. The promotion of endothelial progenitor cells recruitment by nerve growth factors in tissue engineered blood vessels // Biomaterials 2010. Vol. 31. P. 1636- 1645.Zhao Y. L., Zhang S., Zhou J. Y. et al. The development of a tissue-engineered artery using decellularized scaffold and autologous ovine mesenchymal stem cells // Biomaterials. 2010. Vol. 31. P. 296-307.Zhao Y. L., Zhang S., Zhou J. Y. et al. The development of a tissue-engineered artery using decellularized scaffold and autologous ovine mesenchymal stem cells // Biomaterials. 2010. Vol. 31. P. 296-307.Zhou M., Liu Z., Li K. et al. Beneficial effects of granulocyte-colony stimulating factor on small-diameter heparin immobilized decellularized vascular graft // J. Biomed. Mater. Res. 2010. Vol. 95A. P. 600-610.Zhou M., Liu Z., Li K. et al. Beneficial effects of granulocyte-colony stimulating factor on small-diameter heparin immobilized decellularized vascular graft // J. Biomed. Mater. Res. 2010. Vol. 95A. P. 600-610.
The authors declare that there are no conflicts of interest present.